Introduction {#s1}
============

*Wolbachia* are obligate intracellular bacteria infecting arthropods and filarial nematodes ([@bib91]). They promote their maternal transmission by reproductive manipulations, most commonly cytoplasmic incompatibility (CI) ([@bib4]; [@bib7]; [@bib3]; [@bib18]). CI causes zygotic lethality when infected males mate with uninfected females ([@bib29]; [@bib66]). If females have matching infections, embryo viability is normal ([@bib65]). It is thus a gene drive mechanism that selects for infected females.

CI was first studied in the mosquito *Culex pipiens*, which harbors a *Wolbachia* endosymbiont correspondingly named *w*Pip ([@bib44]; [@bib45]). Later, Yen and Barr implicated *Wolbachia* as the CI inducer ([@bib95]; [@bib96]). Several related models have been proposed for the CI mechanism ([@bib4]; [@bib90]; [@bib78]). CI is being applied in mosquito control to sterilize mosquitoes ([@bib15]; [@bib46]; [@bib53]; [@bib97]) and as a population replacement tool harnessing *Wolbachia's* ability to inhibit infectious agents such as dengue and Zika viruses ([@bib88]; [@bib75]; [@bib89]).

In a cross between compatible male and female insects, zygotes follow well described developmental pathways ([@bib52]; [@bib77]). An early step is nuclear envelope breakdown (NEB) of the sperm-derived male pronucleus. The small, highly basic protamine proteins used to package paternal DNA at high density are stripped from the DNA, ([@bib2]; [@bib68]; [@bib83]; [@bib52]; [@bib84]) and nucleosomes are then assembled with maternal histones ([@bib52]; [@bib50]). The protamine-histone transition utilizes specific histone chaperones such as P32 and Nap1 ([@bib27]; [@bib28]). Subsequently, male and female pronuclei come together (but do not fuse) and undergo DNA replication. In the first zygotic mitosis, the two sets of chromosomes condense, align on the metaphase plate, separate in anaphase in parallel and then finally intermingle ([@bib85]).

In CI zygotes, the earliest detected abnormality is impaired maternal H3.3 histone deposition onto the paternal DNA following protamine removal ([@bib42]). Paternal pronuclear NEB is delayed and activity of the cell-cycle kinase CDK1, which normally drives the metaphase-to-anaphase transition, is inhibited in the male pronucleus ([@bib86]). Condensation of the paternal chromosomes is delayed or impaired, often leading to chromosome shearing and bridging during anaphase ([@bib17]; [@bib69]; [@bib74]). This is fatal in diploid insects.

Similar CI cytology has been documented in diverse insects ([@bib85]). Furthermore, artificial transfer of heterologous *Wolbachia* strains into different insect species usually still causes CI ([@bib8]; [@bib13]; [@bib94]). The phenotypic consistency across species suggests that *Wolbachia*-induced CI targets conserved cellular machinery required for cell and nuclear division ([@bib42]; [@bib17]; [@bib69]; [@bib16]). CI might directly disrupt the protamine-histone exchange ([@bib42]); other extra-nuclear sperm factors have been ruled out as targets ([@bib66]). From the results in the current study, we propose that key CI targets include nuclear transport factors (karyopherins) and protamine-histone exchange factors.

Recently, genetic determinants of CI from *Wolbachia*, called CI factors or Cifs, have been identified ([@bib4]; [@bib7]; [@bib3]; [@bib18]; [@bib78]; [@bib48]; [@bib24]; [@bib55]; [@bib49]; [@bib32]). The Cif proteins are encoded by two-gene operons ([@bib7]; [@bib49]) that are commonly found within *Wolbachia* prophage (WO phage) regions termed eukaryotic association modules (EAMs) ([@bib48]; [@bib11]). The *cif* genes, however, have been traced to more ancient bacterial plasmids ([@bib32]). Moreover, the EAM found in WO phages derives from a *Rickettsial* plasmid ([@bib31]). The *cif* genes themselves are found in *Wolbachia*, *Rickettsia,* and *Orientia* ([@bib32]), but *Orientia* and *Rickettsia* generally lack phage. In sum, the *cif* family is diverse and predates *Wolbachia* and its phages ([@bib4]; [@bib32]).

The downstream genes in the *cif* operons, *cidB* or *cinB*, encode enzymatic activities essential to their ability to induce CI when expressed in the germlines of transgenic flies ([@bib4]). They have either deubiquitlyase ([@bib3]) (Ci[d]{.ul}) or nuclease ([@bib18]) (Ci[n]{.ul}) enzymatic functions. The corresponding upstream genes, *cidA* or *cinA*, encode proteins that bind tightly to CidB and CinB proteins, respectively, from the same operon. Dual transgenic expression in *Drosophila melanogaster* of *Wolbachia* CidA and CidB proteins precisely mimics natural CI ([@bib7]; [@bib3]; [@bib48]). We have modeled CI as a toxin-antidote (TA) system with CidB as the toxin and CidA the antidote ([@bib4]; [@bib65]; [@bib38]; [@bib12]; [@bib5]). We annotate Cifs with superscripts identifying the *Wolbachia* strain of origin; for instance, CidB*^w^*^Pip^ is the toxin from the *w*Pip *Wolbachia* endosymbiont of *Culex pipiens* ([@bib4]).

In toxin-antidote (type II) systems in free-living bacteria, toxin and antidote proteins are translated together and bind directly to one another ([@bib93]). Toxicity occurs if cells no longer synthesize the proteins because the antidote protein is degraded much more rapidly than the toxin, thereby releasing active toxin. We posit that CifA and CifB proteins behave similarly ([@bib4]). Not only do CidA and CidB bind together in a cognate-specific manner, but CidA*^w^*^Pip^ coexpression also suppresses CidB*^w^*^Pip^ toxicity in yeast ([@bib3]). The antidote role of CidA has been inferred from bi-directional crosses among infected *C. pipiens* mosquitoes ([@bib9]) and from transgenic *Drosophila* CidA*^w^*^Mel^ and CinA*^w^*^Pip^ experiments ([@bib18]; [@bib78]). As in natural CI, the incompatibility induced by transgenic *cidAB^w^*^Mel^ can be rescued by a cognate maternal *Wolbachia* infection ([@bib48]). Conversely, natural *w*Mel-induced CI can be rescued by transgenic overexpression of CidA*^w^*^Mel^ in mothers ([@bib78]). In transgenic Cid models, incompatibility depends on the CidB deubiquitylase (DUB) activity ([@bib3]). Post-translational ubiquitin modifications alter protein stability, localization, and interactions ([@bib35]; [@bib72]). Active site (C1025A) mutation of CidB*^w^*^Pip^ eliminates CI and CI-like cytology in transgenic insects ([@bib3]). CidB DUB targets are unknown.

Here we focus on identification of CidB targets using both physical and genetic interaction screens. We use yeast and transgenic *Drosophila* to identify dosage suppressors of CidB-derived toxicity. Identification of suppressors of CI may be important beyond aiding in elucidation of CI mechanisms. CI suppression could weaken world-wide *Wolbachia*-based mosquito control efforts and reduce *Wolbachia* equilibrium frequency. Host genes can modulate *Wolbachia*'s reproductive phenotyopes ([@bib37]; [@bib58]; [@bib10]; [@bib23]; [@bib71]), and natural selection favors host suppression of CI ([@bib87]). CI is weak in some host insects, ([@bib23]; [@bib22]; [@bib34]) but in others is strong ([@bib65]; [@bib56]). A CI-inducing *Wolbachia* strain can change its kill ratio in heterologous hosts ([@bib89]; [@bib10]).

We identify karyopherin-α (Kap-α/importin-α), as both a dosage suppressor of CidB toxicity and a CidB binder. Kap-α is a conserved nuclear-import receptor for proteins with classical nuclear localization signals (NLSs) ([@bib19]). After substrate recruitment, Kap-α associates with karyopherin-β and escorts cargo through nuclear pores ([@bib21]). Nuclear Ran-GTP binding releases the cargo, and the karyopherins recycle to the cytoplasm ([@bib33]). CidB-Kap-α interaction connects CI induction and nuclear transport. Our study also highlights CidB association with protamine-histone exchange chaperones P32 and Nap1. Importantly, cognate CidA antidote binding to the CidB toxin eliminates these interactions. These discoveries identify the first potential CI molecular targets that comport with prior cytological observations ([@bib29]; [@bib42]).

Results {#s2}
=======

Host background modulates CidB toxicity in yeast {#s2-1}
------------------------------------------------

Ectopic expression of CidB*^w^*^Pip^ in *Saccharomyces cerevisiae* causes strong temperature-sensitive growth inhibition ([@bib3]). We sought to identify yeast factors modulating CidB*^w^*^Pip^ toxicity. As a first step, we determined whether yeast host background altered toxicity of CidB*^w^*^Pip^ and also tested other *Wolbachia* CI toxins for growth inhibition. Different CI-inducing *Wolbachia* strains have distinct Cif repertoires (we follow [@bib4] in using the Cif term to designate any general CI factor). We previously distinguished three biochemical toxin types ([@bib4]). Ci[d]{.ul} toxins are [D]{.ul}UBs, Ci[n]{.ul} toxins are predicted [n]{.ul}ucleases, and C[nd]{.ul} toxins have both [n]{.ul}uclease and [D]{.ul}UB domains ([@bib4]; [@bib3]; [@bib32]).

When expressing *cidB^w^*^Pip^ in two different yeast backgrounds, BY4741 ([@bib14]) and W303-1A ([@bib82]), we noticed greater sensitivity to its expression in W303-1A ([Figure 1a](#fig1){ref-type="fig"}). Differential sensitivity was also observed with expression of two previously uncharacterized toxin alleles, *cidB^w^*^Ha^ (*w*Ha infects *D. simulans*) and *cndB^w^*^Str^ (*w*Str infects planthoppers). ^FLAG^*cidB^w^*^Pip^ had the strongest toxicity, and ^FLAG^*cndB^w^*^Str^ (truncated after the DUB domain) the weakest. Protein levels of ^FLAG^CndB*^w^*^Str^ showed that variance in toxicity was not simply attributable to differences in protein expression ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Our previous study demonstrated cognate-specific rescue with two *cif* operons ([@bib3]). Here we observed that the Cid-class operon from *w*Ha also showed cognate-specific rescue ([Figure 1b](#fig1){ref-type="fig"}). When *cidB^wHa^* was co-expressed with non-cognate *cifA* genes, either no rescue or even enhanced toxicity was seen. Expression of the CifA proteins alone induced no growth defects ([Figure 1c](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1b](#fig1s1){ref-type="fig"}). These data suggest that yeast genetic background modulates Cif toxicity. This is congruent with observed variance in toxicity in natural CI within insects.

![Cif toxicity in *S. cerevisiae*.\
(**a**) Five-fold dilutions of yeasts BY4741 and W303-1A carrying galactose-inducible epitope-tagged *Wolbachia* genes on pRS416GAL1. Three Cif homologs from *Wolbachia* strains *w*Pip, *w*Ha, and *w*Str showed strong to mild toxicity. All three showed increased toxicity in W303-1A compared to BY4741 (three replicates). (**b**) Toxin-antidote behavior was exhibited by the *cidAB^w^*^Ha^ operon. ^FLAG^CidB*^w^*^Ha^ exhibited toxicity at 36°C when expressed from pRS416GAL1. Co-expression of cognate partner ^FLAG^CidA*^w^*^Ha^ from the 2-micron plasmid pRS425GAL1 rescues growth. Non-cognate partners did not rescue. Conversely, expression of ^FLAG^CinA*^w^*^No^ from a bidirectionally incompatible *Wolbachia* strain *w*No, enhanced toxicity of ^FLAG^CidB*^w^*^Ha^ (four replicates). (**c**) CifA expression alone was nontoxic (three replicates).](elife-50026-fig1){#fig1}

Yeast dosage suppressors of cidB toxicity {#s2-2}
-----------------------------------------

The poor relative growth of the W303-1A yeast strain in the presence of CidB might reflect strain-specific differences in the activities of targets or mediators of CidB toxicity. For example, there may be lower levels in W303-1A compared to BY4741 of a key ubiquitin-protein conjugate that is essential for growth and targeted by the CidB DUB. We therefore sought to identify yeast genes from a high-copy, tiled genomic library that were capable of suppressing *cidB^w^*^Pip^ toxicity ([@bib39]). After rescreening the initial set of isolates ([Supplementary file 1a](#supp1){ref-type="supplementary-material"}; [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}), seven library plasmids showed suppression of toxicity ([Figure 2a--b](#fig2){ref-type="fig"}). A plasmid with the endogenous *URA3* gene served effectively as a positive control for plasmid coverage in the screen inasmuch as yeast transformants with this plasmid no longer needed to retain the *URA3*-based ^His6^*cidB^w^*^Pip^ plasmid to grow on plates lacking uracil. The *URA3* plasmid was identified 16 times, suggesting \~16 fold library coverage.

![Yeast Suppressors of CidB.\
(**a**) Seven library plasmids were high-copy suppressors of CidB*^w^*^Pip^ toxicity. Red genes suppressed when individually sub-cloned. Library plasmid YGPM25o01 includes *URA3* and measures screen efficiency since it is an expected suppressor; Backslashes and brackets denote ORF truncations. (**b**) Five-fold serial dilutions of yeast (W303-1A) with recovered suppressing library plasmids co-transformed with pRS416GAL1-CidB^3xFLAG-*w*Pip^. Library plasmid suppression varied. Suppression by YGPM25o01 (*URA3* control), YGPM26g16, and YGPM32e11 was strong and consistent (three replicates). Plasmids YGPM12h13, YGPM21f02, YGPM32b05, and YGPM11h18, showed weaker and less consistent suppression across four replicates. (**c**) Individual yeast genes *SRP1*, *RTT103*, and *HRP1* suppressed CidB*^w^*^Pip^ toxicity (three replicates). (**d**) Immunoblot analysis confirmed that suppressor plasmids do not reduce CidB expression. CidB and suppressors were controlled by *GAL1* and endogenous promoters, respectively. Asterisk, an unknown cross-reacting yeast protein. Ponceau S staining indicated relative sample loading.](elife-50026-fig2){#fig2}

Individual genes from each genomic insert were subcloned to identify the responsible suppressor. Plasmids with *SRP1*, *RTT103*, *HRP1*, or *FET4* alone suppressed *cidB^3xFLAG-w^*^Pip^-induced toxicity ([Figure 2b,c](#fig2){ref-type="fig"}); *FET4* was the only gene on the weakly suppressing YGPM32b05 plasmid, so it was not subcloned further ([Figure 2a](#fig2){ref-type="fig"}). To rule out suppression of CidB*^3xFLAG-w^*^Pip^ protein levels by the high-copy plasmids, we overexpressed *SRP1* and *RTT103* in yeast cotransformants and found no reduction of CidB*^3xFLAG-w^*^Pip^ ([Figure 2d](#fig2){ref-type="fig"}). Based on the incomplete *RTT103* sequence present on one suppressing plasmid, codons 335--409 were sufficient for suppression ([Figure 2c](#fig2){ref-type="fig"}). *HRP1* encodes an RNA-binding protein involved in processing the 3'-ends of mRNA precursors and mRNA export ([@bib40]). *RTT103* is a transcription termination factor for RNA polymerase II ([@bib60]). *FET4* is an iron transporter ([@bib26]). *SRP1*/*KAP60* encodes the yeast karyopherin-α protein ([@bib51]). *SRP1* was the most robust suppressor (followed by *HRP1*); thus, we focused on this gene.

SRP1 suppression of CidB relies on nuclear import {#s2-3}
-------------------------------------------------

Srp1 has functions beyond nuclear import ([@bib19]). Specific functions can be differentially inactivated by specific point mutations. The mutation S116F (*srp1-31* allele) disrupts binding between Srp1 and substrate NLS elements, while the E145K mutation (*srp1-49* allele) inhibits its function in co-translational protein degradation ([@bib19]; [@bib51]). Only the NLS-binding mutation (S116F) impaired the ability of high-copy *SRP1* to suppress *cidB^w^*^Pip^ toxicity ([Figure 3a](#fig3){ref-type="fig"}). All Srp1 proteins were expressed similarly, so variance in protein abundance cannot account for variation in suppression ([Figure 3b](#fig3){ref-type="fig"}). Conversely, the *srp1-S116F* mutation in the lone chromosomal copy of *SRP1* increased *cidB* toxicity; this synthetic growth defect was most clearly seen with the *cidB^w^*^Ha^ toxin ([Figure 3c](#fig3){ref-type="fig"}). High-copy *SRP1* suppression appeared to be specific to Cid (DUB) toxins insofar as *SRP1* did not suppress the growth impairment caused by the *cinB^w^*^Pip^ paralog ([Figure 3d](#fig3){ref-type="fig"}). These results demonstrate a functional link between *cidB* toxicity and nuclear protein import in yeast.

![Analysis of high-copy *SRP1* suppression of CidB*^w^*^Pip^ toxicity in yeast.\
(**a**) Differential impact of mutations affecting distinct Srp1 functions. An *srp1* mutation impairing NLS binding (S116F) weakened suppression in W303-1A. E145K, which inhibits cotranslational protein degradation, did not impact suppression (three replicates). (**b**) Immunoblot analysis showed equivalent protein levels in *srp1* mutants. Ponceau S staining demonstrated similar loading (three replicates). (**c**) The *srp1-S116F* mutation sensitized W303-1A yeast to ^FLAG^CidB*^w^*^Ha^-induced toxicity in 6/7 replicates. Wild-type *SRP1* complemented the mutation (5^th^ row). Red \* indicates an inactive DUB catalytic mutant control (6^th^ row). Blank columns are empty vectors. (**d**) High-copy *SRP1* did not suppress CinB*^w^*^Pip^ toxicity in BY4741 yeast (three replicates).](elife-50026-fig3){#fig3}

CidB-*Drosophila* protein interactome implicates nuclear transport and nucleosome assembly {#s2-4}
------------------------------------------------------------------------------------------

We created a recombinant expression construct for purification of a catalytically inactive *w*Pip ^His6^CidB derivative bearing a C1025A active-site mutation ([@bib3]). Similarly inactivated DUBs often bind substrates more tightly than their wild-type counterparts ([@bib59]). This protein, ^His6^CidB\*, was expressed in *E. coli* and bound to a cobalt-affinity resin. Lysates from adult *D. melanogaster* flies (both sexes) were passed over the ^His6^CidB\* resin. Enriched proteins were eluted and identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Samples were compared to eluates from mock control columns lacking ^His6^CidB\* ([Figure 4a](#fig4){ref-type="fig"}). From two biological replicates, 169 proteins were enriched on ^His6^CidB\* ([Supplementary file 1b](#supp1){ref-type="supplementary-material"}); this was reduced to 45 proteins based on biological triplicates ([Figure 4b](#fig4){ref-type="fig"}; [Supplementary file 1c](#supp1){ref-type="supplementary-material"}). We classified these top hits into functional categories ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) ([@bib1]). The largest functional category from the screen was 'ribosome structure/biogenesis/translation' with 31% of hits. The second largest category was 'DNA replication/repair/packaging/cell division' with 13%. To identify the most robust hits, we subjected these raw data to peptide spectral analysis (described in Materials and methods).

![Drosophila Interactome Analysis.\
(**a**) Experimental pipeline for defining CidA and CidB interactomes. Soluble lysates from *Drosophila* adults were passed over columns bound to the indicated recombinant proteins and washed. Remaining proteins were eluted and subjected to in-solution LC-MS/MS analysis. (**b**) Venn diagram of protein identifications from raw biological triplicate measurements. The ^His6^CidB\* interactome was dramatically changed when it was bound to ^FLAG^CidA. The interactome of ^His6^CidA itself was modest and showed no overlap with the *Drosophila* proteins bound to either CidB\* or the CidA-CidB\* complex.](elife-50026-fig4){#fig4}

The refined CidB\* interactome is given in [Table 1a](#table1){ref-type="table"}. Eluates were enriched for ubiquitin, which served as a positive control for the DUB substrate trap. The top two hits with the strongest peptide frequency values were both karyopherins, Kap-α2 (a karyopherin-α ortholog of yeast *SRP1*) and Moleskin/Imp-7, a karyopherin-β paralog (which does not associate with karyopherin-α). The ^His6^CidB\* resin also enriched two proteins that function in protamine removal and nucleosome assembly, P32/TAP and, to a lesser degree, Nap1.

###### Final refined interactomes of CidB\**^w^*^Pip^, CidB\*/CidA*^w^*^Pip^, and CidA*^w^*^Pip^ ranked by *F*-Score.

Peptide spectral matches (PSM) of the top enriched proteins are reported. PSMs are reported as the average of three biological replicates, each a summation of 2 technical replicates; (six total samples, three biological replicates). Mock is an *E. coli* negative control without plasmid. P-values were calculated by two sample T-test assuming unequal variances of the replicates. Ubiquitin served as an intrinsic positive control.

  **a ^His6^CidB\* Interactome**                                                                                           
  ----------------------------------------- --------- ------------------ --------------- ------------------ -------------- -------------
  Kap-α2                                    58        IMA_DROME          1.00            10.7               0              0.004
  Moleskin (Kap-β)                          119       Q9VSD6_DROME       0.85            36                 7.7            0.042
  Modulo                                    60        A0A0B4K7G4_DROME   0.83            53.3               11.3           0.048
  P32                                       29        Q7JXC4_DROME       0.76            21                 2.7            0.036
  Vitellogenin-2                            50        VIT2_DROME         0.54            37.3               20             0.092
  Cdep                                      132       A0A0C4DHA1_DROME   0.48            14.3               9              0.121
  l(3)72Ab                                  245       U520_DROME         0.47            22.7               5.7            0.051
  14-3-3zeta                                28        A0A0B4KEH0_DROME   0.45            5                  2              0.015
  Ubiquitin                                 18        RS27A_DROME        0.44            6.7                3              0.065
  Nap1                                      43        Q9W1G7_DROME       0.21            20.3               11             0.122
  b ^His6^CidB\* + ^FLAG^CidA Interactome                                                                                  
  **Protein**                               **kDa**   **UniProt**        ***F*-Score**   **CidB\*/A PSM**   **Mock PSM**   **p-value**
  Pkcdelta                                  207       Q9VYN1_DROME       0.91            14.3               2              0.01
  TfIIFalpha                                64        T2FA_DROME         0.82            12.7               2.7            0.024
  La-related                                161       Y1505_DROME        0.80            7.3                2.3            0.081
  Bunched                                   125       BUN2_DROME         0.79            8                  1.7            0.013
  AP-3 subunit beta                         127       Q9W4K1_DROME       0.74            60                 19             0.012
  AP-3 subunit delta                        115       AP3D_DROME         0.71            56.7               16.3           0.002
  Sals                                      101       Q58CJ5_DROME       0.67            28                 14             0.127
  CG4069                                    56        Q9VTZ7_DROME       0.65            25.3               5.7            0.003
  Ssrp                                      82        SSRP1_DROME        0.65            43                 18             0.014
  Chrac-14                                  14        Q9V444_DROME       0.65            4                  2              0.058
  Dre4                                      128       SPT16_DROME        0.63            62.3               22             0.001
  AP-3mu                                    47        O76928_DROME       0.61            18.7               4.7            0.01
  Shaggy                                    78        A8JUV9_DROME       0.58            27                 11.3           0.025
  CG2025-RA                                 133       Q9VYT3_DROME       0.55            80                 43.7           0.07
  Mical                                     526       A0A0B4K703_DROME   0.48            39.3               20.7           0.01
  Bsf                                       157       Q9VJ86_DROME       0.45            187                105            0.03
  Purple                                    19        PTPS_DROME         0.32            33                 21.7           0.007
  CG11444                                   23        Q9W4J4_DROME       0.26            12.3               8.3            0.014
  c ^His6^CidA Interactome                                                                                                 
  **Protein**                               **kDa**   **UniProt**        ***F*-Score**   **CidA PSM**       **Mock PSM**   **p-value**
  Roe1                                      24        GRPE_DROME         0.97            6                  0              0
  Pi3K92E                                   127       P91634_DROME       0.36            4                  2.3            0.021
  CG17271                                   33        Q9VDI5_DROME       0.30            10                 7              0.095
  Alas                                      59        O18680_DROME       0.29            10.7               6.3            0.043
  CG6984                                    31        Q7K1C3_DROME       0.10            8.3                6.3            0.07

CidA scrambles the CidB-*Drosophila* protein interactome {#s2-5}
--------------------------------------------------------

CidA factors bind specifically to cognate CidB proteins and suppress CidB or *Wolbachia* toxicity in the yeast and insect CI models ([@bib3]; [@bib78]). We hypothesized that CidA 'rescue' is due to CidA association changing CidB interactions with its substrates or cofactors. To test this idea, we repeated the substrate-trap experiments with ^His6^CidB\* bound to the cognate ^FLAG^CidA from *w*Pip. With two biological replicates, 239 proteins were enriched on the CidA-CidB\* column ([Supplementary file 1d](#supp1){ref-type="supplementary-material"}); this was reduced to 67 proteins following analysis of a third replicate ([Supplementary file 1e](#supp1){ref-type="supplementary-material"}; [Figure 4b](#fig4){ref-type="fig"}). These top hits were also sorted into functional categories ([Supplementary file 1e](#supp1){ref-type="supplementary-material"}; [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). In support of the hypothesis that CidA disrupts the CidB interactome, the proteins bound to CidB\* alone and to the CidA-CidB\* complex were completely different except for three proteins, Dek, Non2, and BSF ([Figure 4b](#fig4){ref-type="fig"}; [Supplementary file 1c](#supp1){ref-type="supplementary-material"} cross referenced with [Supplementary file 1e](#supp1){ref-type="supplementary-material"}). Importantly, the nuclear transporters Kap-α2 and Moleskin as well as the histone chaperones P32 and Nap1 were no longer enriched when CidA*^w^*^Pip^ was bound to CidB*^w^*^Pip^. These data are consistent with CidA blocking CidB access to its substrates or cofactors.

The CidA-*Drosophila* protein interactome {#s2-6}
-----------------------------------------

We also identified a *Drosophila* protein interactome for ^His6^CidA*^w^*^Pip^ by itself ([Figure 4b](#fig4){ref-type="fig"}; [Supplementary file 1f and 1g](#supp1){ref-type="supplementary-material"}; [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). CI-relevant targets of the CidB DUB would be predicted to be absent. Indeed, none of ^His6^CidA-*Drosophila* protein interactions identified were part of the CidB\* or CidA-CidB\* interactomes (cross referencing [Supplementary file 1g, 1e and 1c](#supp1){ref-type="supplementary-material"}). Surprisingly few robust ^His6^CidA interactions were identified ([Table 1c](#table1){ref-type="table"}). The three statistically significant hits were a predicted nucleotide exchange factor Roe1, a lipid kinase Pi3K92E, ([@bib47]) and aminolevulinic acid synthase, Alas ([@bib25]). Whether any of these interactions is relevant to CI physiology is unknown. It is possible that CidA has few strong interactions with host proteins by itself, with its main function being tight association with CidB in order to remodel the latter's protein interactome.

Overexpressed *Drosophila* karyopherins and protamine-histone chaperones suppress CI {#s2-7}
------------------------------------------------------------------------------------

Because both the yeast CidB suppressor screen and the *Drosophila* interactome screen identified karyopherin-α, we determined whether increased dosage of karyopherin-α genes might suppress CI in fruit flies, similar to observed results in yeast. *D. melanogaster* has four paralogous karyopherin-α genes (α1, α2, α3, α4) ([@bib63]; [@bib64]). Two of them, Kap-α1 and Kap-α2, were chosen because the first is the closest in sequence to yeast *SRP1* and the second was the top CidB\* interactome hit. In order to test these genes for CI suppression, we switched operons from *cidAB^w^*^Pip^ to *cidAB^w^*^Mel^ as *cidAB^w^*^Pip^ is too toxic and kills all embryos resulting from transgenic male flies. The *cidAB^w^*^Mel^ operon effect is weaker. Suppression in fruit flies was expected to be incomplete, and the CI effects must be weak enough to detect suppression. *w*Mel is also native to *D. melanogaster*.

We first optimized transgenic *cidAB^w^*^Mel^-induced CI under the Gal4/UAS system. CI induction was strongly temperature dependent ([Figure 5a](#fig5){ref-type="fig"}; [Supplementary file 1h](#supp1){ref-type="supplementary-material"}). Although higher growth temperatures caused greater reductions in egg hatch rates, we found 22°C was the optimal temperature for observing partial suppressive effects on CI ([Figure 5b](#fig5){ref-type="fig"}). Expression of either *Drosophila* karyopherin-α paralog in the female germline partially suppressed CI caused by transgenic expression of CidA-B*^w^*^Mel^ in males; yeast *SRP1* did not. When transgenic GFP was used as a negative control, however, it also caused a partial suppression that was not statistically distinguishable from the karyopherin-α suppression. We tried to boost maternal expression in order to increase the relative magnitude of the karyopherin-α effects, but when we switched to the stronger maternal triple driver (MTD), karyopherin-α overexpression in females caused embryos to die independent of CI ([Figure 5c](#fig5){ref-type="fig"}). Thus, the data in [Figure 5b](#fig5){ref-type="fig"} must be interpreted in the context of [Figure 5c](#fig5){ref-type="fig"}. The suppression effects were significant but relatively small because we utilized a weaker driver (NGT) to limit maternal toxicity.

![Suppression of CI in *Drosophila*.\
(**a**) Transgenic CI was temperature sensitive. (**b**) Yeast *SRP1* and *HRP1* did not suppress CI in *Drosophila* and serve as negative controls. At 22°C, overexpression of *D.m.*Kap-α1, *S.c.*Rtt103, GFP, *D.m.*Nap1, *D.m.*Kap-α2, *D.m.*P32 and CidA*^w^*^Mel^ suppressed transgenic CI relative to the control. Both *D.m.*P32 and CidA*^w^*^Mel^ suppression were still highly significant when compared to the GFP control. (**c**) CI suppressive effects of karyopherin overexpression were countered by its maternal toxicity. (**d**) *D.m.* Karyopherins and *D.m.*P32 significantly suppressed bacterial (*w*Mel) CI; GFP did not. Error bars represent means ± s.d. \*p\<0.05, \*\*p\<0.01, \*\*\*\*p\<0.0001 by ANOVA with multiple comparison between all groups and Tukey's post-hoc analysis; four outliers (x) removed by ROUT analysis.](elife-50026-fig5){#fig5}

We next tested whether maternal overproduction of P32 or Nap1 (also identified as a potential CidB substrates or cofactors; [Table 1](#table1){ref-type="table"}) could suppress transgenic CI and found that overexpression of P32 showed highly significant suppression relative to the GFP control, increasing egg hatch rates by \~30% ([Figure 5b](#fig5){ref-type="fig"}). Suppression was equivalent to the rescue observed with transgenic expression of the actual CidA antidote. Importantly, when we measured the suppressive effects of karyopherin-α and P32 overexpression in the female germline in matings with male flies carrying *w*Mel bacterial infections, partial but highly significant suppression was observed for both P32 and karyopherin-α but not for GFP ([Figure 5d](#fig5){ref-type="fig"}). We conclude that the suppression by karyopherin-α and P32 was relevant to natural CI and that the weak suppression by GFP was an artifact of the transgenic CI induction model.

Discussion {#s3}
==========

The *Wolbachia* CidA and CidB proteins were recently found to be central to CI, but no CidB targets were known. Two orthogonal screens of CidB genetic and physical interactions in *S. cerevisiae* and *D. melanogaster*, respectively, identified the nuclear-import receptor karyopherin-α (Kap-α). Kap-α bound to CidB and genetically suppressed CidB-derived defects when overexpressed. The Kap-α NLS-binding site was required for suppression of CidB toxicity. CidB also binds *Drosophila* P32 and Nap1, which promote protamine-histone exchange. Overexpression of either Kap-α or P32 in female insect germlines suppressed natural CI. We also show that CidA in mother flies is sufficient to rescue both transgenic and wild CI.

Notably, CidB-associated proteins such as Kap-α, P32, and Nap1 disappear when affinity purifications are performed in the presence of the antidote CidA. Instead, the CidA-CidB heterodimer has robust interactions with a number of other proteins, many that are not in the nucleus. For example, three of the four subunits of the AP-3 clathrin adaptor complex were identified; AP-3 regulates vesicle trafficking to lysosomes ([@bib62]). These interactions of the complex might tether CidB at sites away from nuclear CI induction targets. The dramatic changes in the CidB-*Drosophila* protein interactome if CidB is bound to CidA suggest the rescue function of CidA acts through alteration of CidB localization or access to key target proteins.

Comparison of model fly and yeast CI systems {#s3-1}
--------------------------------------------

An important question regarding Cid and Cin growth effects in yeast is whether the observed toxicity and suppression occur through mechanisms similar or identical to CI induction and rescue in insects. To date, our data show a striking concordance between the yeast and *Drosophila* analyses, suggesting mechanistic insights into CI can indeed be inferred from yeast studies. First, different yeast strain backgrounds diverge markedly in their sensitivity to the CidB toxin, similar to the wide differences in CI penetrance among various insect host strains ([@bib23]; [@bib71]; [@bib56]). Second, the specific suppression by the CidA*^w^*^Ha^ antidote of the CidB*^w^*^Ha^ toxin in yeast lends further support to the cognate specificity predicted from previous analysis of *cif* operons ([@bib3]; [@bib4]; [@bib5]). The enhanced toxicity caused by noncognate CidA factors when coexpressed with CidB*^w^*^Ha^ may also contribute to incompatibilities in natural populations, although we do not know the mechanism. Third, CidA suppression of CidB toxicity ('rescue') in yeast is now paralleled by analogous observations in transgenic flies ([Figure 5](#fig5){ref-type="fig"}). Females expressing CidA*^w^*^Mel^ alone suppress the incompatibility of males with either transgenic *cidAB^w^*^Mel^ operons or *w*Mel infections. This supports and extends previous studies that demonstrated similar rescue effects with transgenic expression of CidA*^w^*^Mel^ or CinA*^w^*^Pip^ in females ([@bib18]; [@bib78]; [@bib79]). Finally, overexpression of Kap-α both suppressed CidB toxicity in yeast and suppressed *w*Mel-induced CI in flies. We conclude that CI targets conserved pathways in the *S. cerevisiae* and *Drosophila* models.

The fact that GFP weakly suppressed transgenic CI but not wild CI suggests that experiments utilizing the Gal4/UAS systems can produce nonspecific suppression. Cytological studies suggest that CI might have multiple stages. Most embryos die following the first zygotic nuclear division, but escapees die at later stages ([@bib3]; [@bib16]). One possible explanation of the weak nonspecific suppression could be that crosses to mothers with a UAS-driven transgene alleviate a later, secondary stage of CI killing by reducing embryonic expression of the transgenic CidB toxin in older embryos. This might result from binding of the Gal4 transcription factor to the maternal UAS insertions, titrating it from the transgenic *UAS-cidB* gene.

Mechanistic models of CI induction and rescue {#s3-2}
---------------------------------------------

It is not yet clear if the top hits in our screens, such as Kap-α and P32, are deubiquitylated by the CidB enzyme or how this could help account for their functions in CI. Srp1/Kap-α (and Hrp1, another top hit) are known to be ubiquitylated in yeast based on proteomic surveys ([@bib80]). One highly speculative model invokes CidB cleavage of ubiquitin from both Kap-α and histone chaperones such as P32 (or the histones themselves), reducing their functionality. Histone H2A and H2B are well characterized as ubiquitylated proteins, and histone H2B was identified in our CidB\*-binding screen ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Its ubiquitylation may promote histone H3.3 loading and nucleosome formation. There is evidence for ubiquitin-H2B and histone chaperones cooperating in replication-independent nucleosome assembly ([@bib92]).

Ubiquitylation of Kap-α may also be important for its ability to promote nuclear import of a key maternal protein(s) involved in protamine-histone exchange (or for a nuclear non-transport function of Kap-α) ([@bib61]). Our crosses suggest both Kap-α and P32 are limiting in CI embryos because transgenic expression of either suppresses *Wolbachia*-induced incompatibility. In regard to the above model, CidB deubiquitylation of ubiquitin-modified histones, histone chaperones and/or Kap-α would be envisioned to impair histone deposition (but not protamine removal \[[@bib42]\]). Overexpressed Kap-α might enhance import of histone chaperones or ubiquitylation factors to overcome the activity of CidB. Similarly, overexpression of histone chaperones such as P32 could enhance nucleosome assembly. Determination of exactly how the proteins we have identified contribute mechanistically to CI is an important goal for future studies.

The fact that the antidote, CidA, contributes to both CI induction and rescue is seemingly at odds with its designation as an antidote. However, this dual functionality is characteristic of toxin-antidote (TA) operons ([@bib93]). Our previously described model envisioned co-translation of CidA and CidB followed by CidA-B protein complex formation, possibly after passage through a type IV secretion system into the host cytoplasm ([@bib4]; [@bib7]). We postulated that CidA antidote functionality has a dual purpose. One function is to prevent premature toxicity of CidB during spermiogenesis. CidA may even promote localization of the toxin into sperm. Rapid degradation of antidote, also characteristic of TA operons, in the egg would activate the relatively stable CidB toxin if no fresh CidA is provided by egg-resident *Wolbachia*.

To reiterate, induction of CI could proceed by multiple mechanisms based on the data in hand. The simplest model is that CidB directly deubiquitylates a single key target, possibly Kap-α2. In this model ubiquitylated Kap-α2 is crucial for delivery of some key factor, perhaps P32, Nap1, or histones to the male pronucleus. Alternatively, CidB may have multiple direct targets. It might deubiquitylate many of the proteins found in [Table 1a](#table1){ref-type="table"}, for instance, and CI results from the accumulated defects caused by these changes. A more indirect model would posit that CidB binds Kap-α2 as a way into the nucleus where its relevant substrates localize. Localization studies will be crucial for determining the precise mechanisms. 

Based on our fly protein interactome data ([Figure 4](#fig4){ref-type="fig"}), we view \"rescue\" as an exclusion mechanism. In this model, maternal CidA, short-lived but abundantly expressed and provided by *Wolbachia* in infected eggs, associates with the more metabolically stable CidB and prevents the deubiquitylase from binding its relevant target(s). Such binding could also cause changes in CidB localization and/or changes in its substrate preferences.

In general, Nuclear transport as a target of CI is tantalizing because it suggests divergent selfish reproductive manipulators converge on related embryonic processes. Segregation Distorter (SD) was also linked to nuclear import disruption ([@bib57]; [@bib43]). SD is a meiotic driver in natural *D. melanogaster* populations involving two autosomal loci. The *Sd* driver locus encodes a truncated but catalytically active RanGAP (nuclear transport regulator) that mislocalizes to the nucleus ([@bib41]), and the responder (*Rsp*) locus is a large block of satellite DNA. During spermiogenesis, Sd-RanGAP alters the histone-to-protamine transition, culling drive-sensitive spermatids. Phylogenomic analysis of karyopherins in *Drosophila* also suggested frequent gain and loss of Kap-α genes, consistent with selection targeting nuclear transport for host protection against genetic conflicts ([@bib63]). Independently, a *Drosophila* testes-specific X-linked Kap-α gene was found to be duplicated and overexpressed in response to a sex-ratio driver (SR) that selectively blocks maturation of Y chromosome-bearing sperm ([@bib64]). Hence, the molecular features of SD and SR show remarkable parallels with the processes we have linked to CI, particularly nuclear transport (Kap-α, Moleskin) and the protamine-to-histone transition (P32 and Nap1).

Host suppression of CI {#s3-3}
----------------------

Host suppression of reproductive parasitism has been documented in multiple *Wolbachia* systems involving CI ([@bib23]) and male killing ([@bib37]; [@bib70]). Theory predicts that CI will progressively evolve to weaker incompatibilities ([@bib87]; [@bib67]). However specific suppressor gene loci have never been identified. Genetic suppressors of CI are important for two reasons. First, they provide hints toward pathways targeted by CI. Secondly, they might co-evolve as resistance factors to CI. Importantly, suppression of CI in vectors will reduce the effectiveness of global mosquito control efforts harnessing *Wolbachia* and CI. We note that Kap-α and P32 were both robust dosage suppressors of transgenic and natural CI ([Figure 5](#fig5){ref-type="fig"}) and both are maternally deposited ([@bib27]; [@bib28]; [@bib54]). Therefore, these proteins could well be important factors in the evolution of host resistance to *Wolbachia*-induced CI.

Materials and methods {#s4}
=====================

Nucleic acid sources and construct preparation {#s4-1}
----------------------------------------------

Yeast genomic DNA was purified by lysing cells by glass bead disruption, followed by phenol/chloroform extraction and ethanol precipitation ([@bib36]). *Wolbachia* DNA was purified by homogenizing 10 whole infected insects in lysis buffer and recovering DNA with organic extraction following referenced protocols ([@bib3]; [@bib6]). *Drosophila melanogaster* and *D. simulans* lines infected with *w*Mel, *w*Ri, and *w*Ha were used as PCR template sources. In some cases, genes from *w*No and *w*Mel were subcloned from synthesized constructs (Genscript). Genomic *w*Str DNA was a gift from Ann Fallon and was derived from infected cell cultures. PCR amplicons were produced with primers listed in [Supplementary file 1i](#supp1){ref-type="supplementary-material"}. High fidelity Phusion polymerase (New England Biolabs) was used to amplify DNA, which was then restriction enzyme digested, gel-purified and ligated into various plasmid vectors ([Supplementary file 1j](#supp1){ref-type="supplementary-material"}). Plasmids were sequenced and confirmed at the Yale Keck Foundation DNA sequencing facility. Point mutations were introduced by QuikChange site-directed mutagenesis (Stratagene). Other modifications such as truncations or tag additions/swaps were created by site-directed ligase-independent mutagenesis (SLIM) ([@bib20]).

Yeast methods {#s4-2}
-------------

Yeast strain backgrounds used were W303-1A and BY4741. BY4741 was discontinued after [Figure 1a](#fig1){ref-type="fig"} because W303-1A exhibited stronger sensitivity to CI factors. All other serial dilution and Western blotting data used W303-1A except [Figure 3d](#fig3){ref-type="fig"} which was BY4741. Yeast were transformed with plasmids by standard methods ([@bib30]). In general, *cifB* gene toxins were expressed from low-copy CEN vectors under control of the *GAL1* promoter. When testing co-expression with *cifA* genes or suppressors we placed these latter genes in high-copy 2-micron plasmids, with the *cifA* genes also under control of the *GAL1* promoter. Suppressors were always expressed under endogenous promoters. For specific plasmid descriptions see the construct database, [Supplementary file 1j](#supp1){ref-type="supplementary-material"}. Five-fold serial dilutions and plating of yeast cultures were described previously ([@bib3]). SDS-PAGE and Western blotting analysis of yeast protein extracts was performed precisely as detailed in our prior work ([@bib3]). All serial dilution and Western blot data are representative of at least three biological triplicate experiments.

Yeast suppressor screens {#s4-3}
------------------------

Plasmids from a yeast high-copy ordered genomic library were purified from *E. coli* (Qiagen) and stored at −80°C ([@bib39]). ^His6^*CidB^w^*^Pip^ was cloned into the pRS416GAL1 plasmid using BamHI-5' and XhoI-3' restriction sites. This low-copy CEN plasmid has a galactose-inducible promoter and a *URA3* cassette. Suppressor screens were performed in the BY4741 yeast background. BY4741 \[pRS416GAL1-^His6^*CidB^w^*^Pip^\] yeast were streaked out on synthetic defined (SD) glucose medium lacking uracil (SD-ura). An overnight liquid starter culture (5--10 ml) was inoculated in SD-ura medium at 30°C. The following day, cultures were diluted and allowed to grow to OD~600~ 0.8 in SD-ura at 30°C. Cells were pelleted by centrifugation, washed in sterile water and transformed using lithium acetate transformation with 17 sublibrary plasmid minipreps ([@bib30]).

Transformed cells were plated directly on selective medium (synthetic defined galactose medium lacking uracil and leucine) at a range of temperatures. This selects for the *URA3* and *LEU2* markers in the toxin-expressing and library plasmids, respectively, and galactose induces expression of ^His6^*CidB^w^*^Pip^ which kills yeast unless they carry a suppressor. More than five iterative screens were performed under varying conditions, including temperatures of 37, 36.5, 34, and 33°C. We also tested variant strategies of plating transformants on the selective media. If we first plated cells on glucose media, allowed the transformants to grow into colonies, and then replica-plated onto galactose media, it yielded high background and more false positives. These methods and the plasmids identified are summarized in [Supplementary file 1a](#supp1){ref-type="supplementary-material"}.

After plating on selective media, colonies were allowed to grow for 3--7 days, which helped colony sizes diverge according to suppressive capability. Potential suppressors were then re-streaked under the same selective conditions. Yeast colonies were then inoculated into 2 ml of yeast peptone dextrose (YPD) liquid medium and allowed to grow for two days to high density. Cultures were used for 'smash-n-grab' plasmid recovery ([@bib36]). Recovered DNA was electroporated into electrocompetent Top10F' *E. coli* and plated on LB plates containing kanamycin. The ends of the recovered plasmid inserts were sequenced with primers JFB 146 and 147 ([Supplementary file 1i](#supp1){ref-type="supplementary-material"}). Sequencing data were cross referenced with the *S. cerevisiae* genome using NCBI BLAST ([Figure 2a](#fig2){ref-type="fig"}, [Supplementary file 1a](#supp1){ref-type="supplementary-material"}). Identified plasmids were re-transformed back into yeast and tested by serial dilution to confirm suppression ([Figure 2b](#fig2){ref-type="fig"}). To identify individual suppressor genes from these library plasmids, we sub-cloned each gene individually into the library vector pGP564. These clones were then transformed into yeast and tested by serial dilution ([Figure 2c](#fig2){ref-type="fig"}).

Recombinant protein expression and substrate trapping interactomes {#s4-4}
------------------------------------------------------------------

All recombinant protein expression constructs and isolation protocols were described previously ([@bib3]). We used similar protocols with some minor modifications listed here. Recombinant proteins were expressed in BL21-AI (ThermoFisher). N-terminally His6-tagged proteins expressed from an arabinose inducible promoter in the plasmid pBAD (ThermoFisher) were purified by affinity chromatography using HisPur cobalt resin (Qiagen). Three constructs were used to produce three interactomes in ([Figure 4](#fig4){ref-type="fig"}): ^His6^CidA*^w^*^Pip^, ^His6^CidB\**^w^*^Pip^ (C1025A), and ^FLAG^CidA*^w^*^Pip^. *Drosophila melanogaster* lysates (male and female adults) were run over the column to enrich for insect proteins capable of binding the recombinant proteins. For detailed expression, purification, and pull-down protocols, see below. In-solution LC-MS/MS analysis was performed at the Yale Keck Foundation in close association with the authors (for details see below).

Transgenic *Drosophila* and transgenic CI crosses {#s4-5}
-------------------------------------------------

DNA for the *cidA-T2A-cidB^w^*^Mel^ operon ([@bib3]), in addition to D.m.Kap-α1 were codon optimized for *Drosophila* and ordered from Genscript. Some constructs were purchased from Genscript *Drosophila* cDNA libraries. Transgenes were sub-cloned from the pUC57 vector into pUASp-attB ([@bib73]; [@bib81]). This vector appends the K10 3' UTR, which is known to localize transcripts to the *Drosophila* oocyte ([@bib76]). Final constructs were either fully sequenced or sequenced on ends and verified by restriction enzyme digests. Cloning and construct specifics are in [Supplementary file 1j](#supp1){ref-type="supplementary-material"}. BestGene Inc was contracted for embryo microinjection of *D. melanogaster* \#9744 (attP site on chromosome three) and ΦC31 integrase-mediated transgene insertion. We verified that all fly lines were free of *Wolbachia* using PCR and primers recognizing a conserved region in the *Wolbachia* VirD4 gene ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). As a positive control, we amplified the *D. melanogaster* histone H3 gene. Crossing of *cidA-T2A-cidB^w^*^Mel^ operon-transformed male flies with females from strain \#4442 carrying the nanos-Gal4-tubulin 3' untranslated region (NGT) driver induced CI ([Figure 5a](#fig5){ref-type="fig"}). This served as a phenotypic confirmation of transgene expression and accords with previous results ([@bib3]; [@bib48]).

Flies were maintained on a standard diet, and temperature was stringently controlled as outlined in [Figure 5](#fig5){ref-type="fig"}. For CI analysis, F~0~ crosses were initiated by crossing homozygous Gal4 driver females to homozygous UAS-transgene males. F~0~ crosses were kept at the temperatures indicated in [Figure 5](#fig5){ref-type="fig"} to control for any temperature-dependent maternal effects. Temperature was only temporarily lowered to 18°C for overnight virgin collection. F~1~ flies, which were heterozygous for both the NGT driver and the Gal4-UAS-transgene, were aged 3--4 days at restrictive temperature and crossed one to one, male and female, in arenas with apple juice plates and yeast paste. After 12 hr, we discarded the original apple juice plate and allowed flies to oviposit for 24 hr before removing the plate. Eggs were given 36 hr to hatch while being incubated at the respective temperatures. Hatch rates were evaluated by microscopy and by counting hatched and unhatched egg totals. One-way ANOVA with multiple comparison was performed using Graphpad Prism seven with outliers removed by the ROUT method. Flies used in this study were *white* Canton-S (^w^CS; WT); *nanos-Gal4-tubulin*, \#4442; MTD-Gal4, \#31777, which has multiple GAL4 inserts on all three large chromosomes, including *nanos-Gal4*, *nanos-Gal4:VP16*, and *otu-Gal4* and is infected with *Wolbachia*; and UASp-Kap-α2, \#25400 ([@bib54]). Fly lines were created by us, obtained from the Bloomington Stock Center, or were gifts.

Rationale for dual CidA and CidB transgenic CI expression {#s4-6}
---------------------------------------------------------

The cidB*^w^*^Pip^ gene alone was not successfully inserted into flies in \>600 embryo microinjections ([@bib3]). Our interpretation of this observation was that CidB*^w^*^Pip^ might be toxic by itself and was killing the injected flies. In order to build a transgenic fly that expressed CidB*^w^*^Pip^, we reasoned that co-expressing it with the upstream CidA*^w^*^Pip^ protein might alleviate this toxicity. We built the fusion ORF cidA*^w^*^Pip^ --T2A--cidB*^w^*^Pip^, where T2A encodes a viral peptide that causes ribosomal skipping and translation of the upstream and downstream polypeptides at roughly 1:1 stoichiometry. This worked. Importantly, this system mimics what would occur in a normal *Wolbachia* infection and other natural toxin-antidote systems in which both proteins are expressed simultaneously. Toxicity in most known toxin-antidote systems occurs only after rapid degradation of the antidote in cells that no longer synthesize it. This activates the toxin. We hypothesized that the reason CI was induced was because there was a similar rapid degradation of CidA antidote in the fertilized egg, although this remains to be shown experimentally ([@bib4]; [@bib3]).

In [@bib48] CI factors from another *Wolbachia* strain were used, namely CidA-CidB*^w^*^Mel^. The CI system of *w*Mel has traits making it different from the *w*Pip system described above. It is a much weaker CI inducer. In that publication, a transgenic fly line with cidB*^w^*^Mel^ alone was generated and did not induce CI. Only when combined with an insertion of cidA*^w^*^Mel^ on another chromosome was CI induced. The requirement for both proteins for CI in these transgenic models could either be that both are needed for interference with embryonic nuclear division or, as suggested above, that CidA promotes CI indirectly by preventing premature toxicity of CidB in the male and/or promoting CidB packaging into sperm. Because this dual expression system was able to induce transgenic CI, we replicated it with the *w*Mel operon in this study except via a T2A peptide mechanism.

Detailed protein expression, purification, and pull-down analysis {#s4-7}
-----------------------------------------------------------------

Bacterial starter cultures were grown overnight and used to inoculate 4 liters of Luria Broth (LB) plus ampicillin. An additional 4-liter culture of BL21-AI cells was always grown in tandem to serve as an internal mock negative control with which to rule out non-specific interactions from copurification analyses; the mock control and experimental samples were treated equivalently. Cultures were grown at 37°C with vigorous shaking to an optical density at 600 nm of 0.5 and induced with 0.02% arabinose. Immediately after induction, we shifted the cultures to 18°C and incubated overnight. The following morning cells were pelleted by centrifugation and resuspended in 15 ml of 50 mM Tris pH 8.0, 250 mM NaCl, 10% glycerol, 2 mM β-mercaptoethanol. We added 100 μl of 100 mM PMSF in isopropanol and one cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail tablet (Roche).

Cells were lysed by incubation with a pinch of chicken egg-white lysozyme on ice for 30 min followed by two passes through a French-press. Lysate was centrifuged for 45 min at 30,000 x *g* (Beckman Coulter Type 50.2 TI). Following centrifugation, supernatant was decanted in a beaker on ice with a stir bar. In order to precipitate and remove DNA, we added 5 M NaCl while stirring to a final concentration of 1 M and poly(ethyleneimine) (PEI) from a stock of 10% PEI in 10% HCl to a final concentration \~0.3--0.5%. Fresh PEI solution was used to ensure efficient DNA precipitation. DNA was precipitated after 5 min stirring on ice and pelleted by centrifugation at 4700 x *g* for 15 min in a Thermo Sorvall Lynx 600 F9−6 × 1000 LEX centrifuge. Supernatant was transferred to a new tube and proteins gently precipitated by adding 0.436 g/ml ammonium sulfate on ice while stirring for 15 min. Precipitated proteins were then pelleted at 30,000 x *g* for 30 min and the supernatant removed.

Protein pellets were resuspended in wash buffer (50 mM sodium phosphate pH 8.0, 300 mM NaCl, 0.01% Tween-20, 5 mM β-mercaptoethanol, 10 mM imidazole) and run over a 10 ml disposable chromatography column containing 1 ml of fresh HisPur cobalt resin at 4°C to bind recombinant His6-tagged proteins. The columns were washed with 20 column volumes (20 ml) of wash buffer. A peristaltic pump was used to aid column flow. *Drosophila* lysates made from male and female adults were then run through the column. To prepare *Drosophila* lysates, 10 ml of fly bodies were collected and stored in −80°C. Bodies were ground to powder in liquid nitrogen by mortar and pestle and 25 ml of pull-down buffer (3.25 mM Sodium-phosphate, pH 7.4, 70 mM NaCl, 0.01% Tween-20) was added. Fly cuticle and insoluble material were pelleted by centrifugation at 4700 x g for 15 min in a Thermo Sorvall Lynx 600 F9−6 × 1000 LEX centrifuge and the supernatant was passed through a 5-micron filter (Amicon), loaded on the HisPur-recombinant protein column, and allowed to pass through the column by gravity for 1 hr. The column was then washed with 50 column volumes (50 ml) of wash buffer. Proteins were eluted with 5 ml of elution buffer (300 mM imidazole, 50 mM Sodium-phosphate pH 8.0, 300 mM NaCl, 0.01% Tween-20). Eluates were concentrated to 250 µl in an Amicon 3000 molecular weight cutoff centrifugal filter. Concentrated eluates were then subjected to in-solution proteome analysis as described below. In the case of the bound ^His6^CidB\**^w^*^Pip^/^FLAG^CidA*^w^*^Pip^ interactome, ^FLAG^CidA*^w^*^Pip^ was added as a bacterial extract, followed by an additional wash with 20 column volumes wash buffer, and then immediate addition of the fly lysate.

Protein digestion {#s4-8}
-----------------

Proteins were precipitated from the eluates with acetone using established protocols. Protein pellets were dissolved and denatured in 8 M urea, 0.4 M ammonium bicarbonate, pH 8. The proteins were reduced by the addition of 1/10 vol of 45 mM dithiothreitol (Pierce Thermo Scientific \#20290) and incubation at 37°C for 30 min, then alkylated with the addition of 1/10 vol of 100 mM iodoacetamide (Sigma-Aldrich \#I1149) with incubation in the dark at room temperature for 30 min. The urea concentration was adjusted to 2 M by the addition of water prior to enzymatic digestion at 37°C with trypsin (Promega Seq. Grade Mod. Trypsin, \# V5113) for 16 hr. Protease:protein ratios were estimated at 1:50. Samples were acidified by the addition of 1/40 vol of 20% trifluoroacetic acid, then desalted using C18 MacroSpin columns (The Nest Group, \#SMM SS18V) following the manufacturer's directions. Peptides were eluted with 0.1% TFA, 80% acetonitrile. Eluted peptides were dried in a Speedvac and dissolved in MS loading buffer (2% aceotonitrile, 0.2% trifluoroacetic acid). Protein concentrations were determined using a Thermo Scientific Nanodrop 2000 UV-Vis Spectrophotometer. Each sample was then further diluted with MS loading buffer to 0.08 µg/µl, with 0.4 µg (5 µl) injected for LC-MS/MS analysis.

LC-MS/MS {#s4-9}
--------

LC-MS/MS analysis was performed on a Thermo Scientific Orbitrap Fusion equipped with a Waters nanoAcquity UPLC system (Yale Keck Center) utilizing a binary solvent system (Buffer A: 100% water, 0.1% formic acid; Buffer B: 100% acetonitrile, 0.1% formic acid). Trapping was performed at 5 µl/min, 97% Buffer A for 3 min using a Waters Symmetry C18 180 µm x 20 mm trap column. Peptides were separated using an ACQUITY UPLC PST (BEH) C18 nanoACQUITY Column 1.7 µm, 75 µm x 250 mm (37°C) and eluted at 300 nl/min with the following gradient: 3% buffer B at initial conditions; 5% B at 5 min; 20% B at 90 min; 35% B at 125 min; 97% B at 130 min; 97% B at 135 min; and return to initial conditions at 136--150 min. Mass spectra were acquired in the Orbitrap in profile mode over the 300--1,500 m/z range using quadrapole isolation, one microscan, 120,000 resolution, AGC target of 4E5, and a maximum injection time of 60 ms. MS/MS data were collected in top speed mode with a 3 s cycle time on species with an intensity threshold of 5E4, charge states 2--8, peptide monoisotopic precursor selection preferred. Dynamic exclusion was set to 30 s. Data-dependent MS/MS were acquired in the Orbitrap in centroid mode using quadropole isolation (window 1.6 m/z), HCD activation with a collision energy of 28%, one microscan, 60,000 resolution, AGC target of 1E5, maximum injection time of 110 ms.

Peptide identification {#s4-10}
----------------------

Data were analyzed using Proteome Discoverer software v2.2 (Thermo Scientific). Data searching was performed using the Mascot algorithm (version 2.6.1) (Matrix Science) against a custom database containing protein sequences for CidA and CidB\* as well as proteomes for *Escherichia coli*, *Saccharomyces cerevisiae*, *Wolbachia pipientis*, and *Drosophila melanogaster* proteomes (35,536 sequences total). The search parameters included tryptic digestion with up to two missed cleavages, 10 ppm precursor mass tolerance and 0.02 Da fragment mass tolerance, and variable (dynamic) modifications of methionine by oxidation and carbamidomethylated cysteine. Normal and decoy database searches were run, with the confidence level set to 95% (p\<0.05). Scaffold (version Scaffold_4.8.9, Proteome Software Inc, Portland, OR) was used to validate MS/MS-based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 95.0% probability by the Scaffold Local FDR algorithm. Protein identifications were accepted if they could be established at greater than 99.0% probability and contained at least two identified peptides.

Interactome data analysis {#s4-11}
-------------------------

Samples were each run in technical duplicate with three independent biological replicate interactome pulldowns constituting a complete interactome dataset. Proteomic datasets were viewed in Scaffold Proteome Software and the raw datasets of identified peptide spectral matches were transitioned into Microsoft Excel. Protein 'enrichment' was measured in comparison to an internal mock control lacking recombinant protein. We ranked protein hits based on normalization of the frequency of detecting their peptide spectra in the experimental pulldown compared to the mock control. The peptide frequency (*F*) for any protein hit was calculated by the formula:$$F = \frac{\left( {C - M} \right)}{C}$$where *C* equals the total number of peptide spectral matches for any protein X detected in the CidB\* sample (i.e., recombinant protein sample) and *M* is equal to the total peptide spectral matches for the same protein X detected in the mock (negative control) sample. By this calculation, protein hits with spectra uniquely present in a CidB\* pull-down and also completely absent in the control have a perfect value of 1. If there is no difference in spectra and no *enrichment* the value will equal 0. Thus, proteins *enriched* can be ranked on a scale of 0 - 1 and anything not enriched will be less than or equal to zero. Proteins enriched in at least two of three replicates were compiled in Excel ([Supplementary file 1b, d and f](#supp1){ref-type="supplementary-material"}). We then iteratively subjected these lists to peptide spectral analysis. In this order, we culled the lists to proteins identified as *enriched* (*F* ≥ 0) in all three biological replicates for each interactome ([Supplementary files 1c, e, g](#supp1){ref-type="supplementary-material"}). Next, we classified these hits based on predicted protein functional categories ([Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}, [2,](#fig4s2){ref-type="fig"} and [3](#fig4s3){ref-type="fig"}). Then we a) eliminated hits where averages covered up inconsistencies in the technical replicates; such hits may have had multiple peptides in one technical replicate, but zero in another; b) removed hits with standard deviations in their *F*-scores greater than that of our positive control, ubiquitin; c) removed ribosomal subunits (though these hits are still visible in [Supplementary file 1c, e and g](#supp1){ref-type="supplementary-material"}); and d) manually inspected the tandem spectra verifying that they all contained at least three consecutive ions, ie., b5, b6, b7 and that all peaks above background were assigned to the peptide. This process produced *final* interactomes ([Table 1](#table1){ref-type="table"}). Proteins were not reported in any table if the combination of technical replicate enrichment was not ≥ 2. Under these stringent reporting conditions, the false discovery rate (FDR) of the interactomes is zero. P-values were calculated (comparing peptide spectral matches in *C* to *M*) by a two sample T-test assuming unequal variances of the total replicates.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The ability of intracellular parasites like *Wolbachia* to induce cytoplasmic incompatibility (CI) - in which the presence of the bacteria in one or both germ cells leads to the production of inviable gametes - has been studied for decades as a window into the complex interactions between symbionts and their hosts. These studies have become more urgent in recent years as such systems are increasingly being deployed in the field to control populations of disease vectors, especially mosquitos. The authors of this work previously identified a *Wolbachia* toxin CidB that induces CI and a corresponding antitoxin CidA that suppresses it. This paper addresses the question of what processes are targeted by CidB, using a combination of genetic screens and biochemistry to identify a nuclear import factor and a factor involved in the packaging of sperm DNA as likely targets, which they confirm with follow up functional studies. The reviewers found the experimental design and execution to be of uniformly high quality, and the data convincing. Given the abundance of manuscripts on the phenomenology of CI, mechanistic studies such as the one presented here are essential, and certain to be of immediate interest to both the symbiosis and vector control communities.

**Decision letter after peer review:**

Thank you for submitting your article \"*Wolbachia* Cytoplasmic Incompatibility Enzyme CidB Targets Nuclear Import and Protamine-Histone Exchange Factors\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Michael Eisen as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: William Sullivan (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The manuscript by Beckmann et al. follows up previous studies that identified the genes responsible for *Wolbachia*-induced CI and rescue. Over the past decade the relevance of these studies has greatly increased because of mass releases of *Wolbachia*-infected mosquitos to prevent insect borne diseases. This strategy relies on *Wolbachia*-induced CI, thus elucidating the underlying mechanisms has immediate relevance for vector control.

Previously the authors identified *Wolbachia*-expressed CidB, a deubiquitylase (DUB), as causing CI and *Wolbachia* Cid A as the maternal rescuing element. Using a yeast expression system and binding assays they provided strong experimental support for CidB and CidA operating as a toxin antitoxin respectively.

Here, using parallel screens in yeast and flies, they uncover candidate targets of the *Wolbachia* toxin, CidB. One target that emerged from both screens is the nuclear import factor, karyopherin. The authors show that overexpression of this factor in *Drosophila* embryos suppresses CidB toxicity (embryo viability increases). Similarly, overexpression of P32, a factor uncovered only by their CidB protein interaction search using *Drosophila* adult lysate, also suppresses CidB toxicity in vivo. These discoveries identify not only key molecules and mechanisms controlling CI (with implications for insect vector and pest biology), but also possibly a new maternal factor that processes the paternal genome in the early embryo (in the absence of *Wolbachia* infection). The experimental design and quality of the data is excellent and with a few exceptions the writing is clear and concise.

Given the overabundance of manuscripts on the phenomenology of CI, mechanistic studies such as these are essential sorely needed contributions and certain to be of immediate interest to the symbiosis and vector control communities. However the reviewers raised a number of issues that must be addressed prior to acceptance:

Essential revisions:

1\) A major strength of the paper is the convergence of a candidate CidB target from yeast and *Drosophila*-based assays. The toggling between different *Wolbachia* strains throughout the paper suggests common mechanisms of CI. However, the authors also emphasize the CidB toxin requires cognate CidA for potent suppression (e.g., Figure 1B). The authors need to address the seemingly paradoxical strain-specificity of the *Wolbachia* Cif protein interactions and the putative kingdom-wide conservation of CidB targets. The results are especially surprising given the expectation that these host targets evolve rapidly to evade *Wolbachia* antagonism.

2\) The data presented in Figure 5 (demonstrating suppression of *Drosophila* CI through maternal expression of genes identified in the screen) needs clarification:

a\) Based on Materials and methods, each data point is an egg lay from 1X1 mating and the% hatch. To evaluate this an N (total number eggs) needs to be included for each 1X1 mating). For each cross, it would also be useful to have the sum of total \# hatched/total \# of eggs. Also the data points with many eggs and no hatch are likely due to laying of unfertilized eggs from unmated females -- these should be excluded from the analysis.

b\) A clearer explanation needs to be given concerning the rescuing effect of the GFP alone compared to the karyopherin and accounting for karyopherin induced lethality.

c\) The fact that a diverse array of transgenes result in rescue is intriguing suggesting may be also occur through non-specific effects (slowing develop etc). This would also fit with the studies presented demonstrating different yeast backgrounds exhibit different toxicities (Figure 1).

d\) For those not intimately familiar with recent CI literature, it would be helpful to include an explanation of why expression of both CidB/CidA is being driven in the male (Given the toxin (CidB)/ Antitoxin (CidA) model presented the rational for this approach is not obvious). The dual expression is also described in their Introduction with no additional explanation. Perhaps these sections could point the reader to an expanded Materials and methods section where the rational is fully explained.

3\) Figure 5 strongly supports the capability of both P32 and Kap-α to suppress CI in the embryo. The relevance of P32 to CI is clear \-- maternally deposited P32 processes sperm-deposited paternal chromosomes in uninfected embryos and in CI, the paternal chromosomes fail to condensed properly at the first zygotic prophase. However, Kap-α has yet to be implicated in paternal genome processing post-fertilization. Do we know if Kap-α is maternally deposited? The absence of either IF- or Western -- based evidence that Kap-α is detectable prior to zygotic genome activation weakens the implied relevance of Kap-α to CI in nature. This needs to be addressed by the authors.

4\) Related to above, do the authors imagine that the toxin targets different developmental events between sperm entry and the first zygotic division and that is why targets with different roles in this process emerged from the *Drosophila*-based screen? Do the authors imagine Kap-α and P32 act independently during this short developmental stage? What is the model?

5\) Also related to the above, a model that reconciles previous work showing that the earliest CI-defect in *Drosophila* embryos appears at prophase with the current work that shows that, based on CidB targets, CI compromises transition to nucleosome-based chromatin on paternal DNA. Based on the discovery that CidB binds P32, we would expect instead that sperm-deposited DNA would fail to decondense after sperm entry and ultimately fail to participate at all in the first zygotic mitosis.

6\) The proteomic analysis demonstrates that CidA binding to CidB\* does not compromise interactions with other proteins. The (surprisingly?) expanded set of interactors under this treatment warrants further comment.

7\) The Introduction could benefit tremendously from some restructuring and addition of important background information. For example, the second paragraph of the Introduction asserts that \'CidA and CidB proteins precisely mimic naturel CI.\' However, the reader does not yet know what \'natural CI\' looks like. Indeed, the word \"embryo\" has not yet appeared in the Introduction. The fifth paragraph of the Introduction could be moved up to help explain natural CI. In addition, CidB*^w^*^Pip^ (Introduction, second paragraph) is not explicitly defined as derived from *Culex pipiens*. The third paragraph of the Introduction could also benefit from additional information about how CidA is \'inferred from bi-directional crosses.\" Generally, the Introduction appears to be written in \"short format\" and so fails to completely introduce the system to the uninitiated reader.

8\) Where are the data for the high copy suppressor plasmids encoding the other sub-cloned genes that did not exhibit suppressor activity? (Subsection "Yeast Dosage Suppressors of cidB Toxicity, last paragraph; Figure 2). These data should be included as supplement.

9\) Why were only Kap-α and P32 used in the final CI suppression assay? Do the other candidates not suppress CI?

10\) The Discussion does not directly address many of key findings of the manuscript and how it relates to previous work on CI. For example, the Abstract states \"CidB targets nuclear-protein import and protamine-histone exchange and that CidA rescues embryos by restricting CidB access to its target\" yet no mention is made of this idea in the Discussion. There are other examples as well.
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Author response

> Essential revisions:
>
> 1\) A major strength of the paper is the convergence of a candidate CidB target from yeast and Drosophila-based assays. The toggling between different Wolbachia strains throughout the paper suggests common mechanisms of CI. However, the authors also emphasize the CidB toxin requires cognate CidA for potent suppression (e.g., Figure 1B). The authors need to address the seemingly paradoxical strain-specificity of the Wolbachia Cif protein interactions and the putative kingdom-wide conservation of CidB targets. The results are especially surprising given the expectation that these host targets evolve rapidly to evade Wolbachia antagonism.

There is no real paradox here. The specificity of "rescue" is conveyed by cognate CidA-CidB binding but toxin substrate specificity is expected to derive from the "warhead" of CidB, which is the deubiquitylase (DUB) domain. The targets of the DUB activity can be the same even across phylogenetically diverse taxa. Differential binding among various CidA and CidB variants, and therefore the possibility of rescue, is predicted to be due to sequence differences in their binding interfaces. Examination of sequence variation in CidA and CidB alleles compared to crossing type diversity among geographically separated *Culex pipiens* mosquito populations infected with *w*Pip *Wolbachia* variants is fully consistent with this view. Rescue through antidote binding to the CidB toxin does not result from direct inhibition of the DUB catalytic site by CidA; instead, it appears to be a consequence of limiting access of the toxin to its key targets in vivo. We have addressed these points in the revised Discussion section.

> 2\) The data presented in Figure 5 (demonstrating suppression of Drosophila CI through maternal expression of genes identified in the screen) needs clarification:
>
> a\) Based on Materials and methods, each data point is an egg lay from 1X1 mating and the% hatch. To evaluate this an N (total number eggs) needs to be included for each 1X1 mating).

We agree. We have included the N values on the righthand side of the figure for each cross.

> For each cross, it would also be useful to have the sum of total \# hatched/total \# of eggs.

We agree. We have added the additional Supplementary file 1H with this data.

> Also the data points with many eggs and no hatch are likely due to laying of unfertilized eggs from unmated females -- these should be excluded from the analysis.

We agree; We hypothesize that unmated females lay fewer eggs than mated females. In our hands, healthy mated females lay around 30 -- 90 eggs. In our datasets, we excluded egg lay data if the females lay \< 5 eggs. Thus, we have done our best to eliminate possible data relics induced by unmated females through this process. We also point out that our controls do not have any unmated females (values of zero hatch-rate), so we do not feel this issue impacts our datasets.

> b\) A clearer explanation needs to be given concerning the rescuing effect of the GFP alone compared to the karyopherin and accounting for karyopherin induced lethality.

We have attempted to clarify this in the modified text; please see 2c response below.

> c\) The fact that a diverse array of transgenes result in rescue is intriguing suggesting may be also occur through non-specific effects (slowing develop etc). This would also fit with the studies presented demonstrating different yeast backgrounds exhibit different toxicities (Figure 1).

We agree that in the transgenic CI experiments, non-specific suppression was observed, although non-specific suppressive effects were typically weak (\~15% in the case of GFP). Thus, we only inferred mechanistically relevant suppression in cases where the observed suppression was significantly greater than with GFP. With P32 and Kap-α2 we also saw strong suppression against natural CI (males infected with *w*Mel), and in that case non-specific suppression did not result when crossed to females expressing GFP.

The fact that GFP weakly suppressed transgenic CI but not natural *Wolbachia*-induced CI suggests that experiments utilizing the Gal4/UAS systems can produce non-specific suppression. Toxicity due to CI might occur at multiple stages. Some embryos die in the first round of zygotic nuclear division, with escapees dying at later stages (Beckmann, Ronau and Hochstrasser, 2017; Callaini et al., 1996). One possible explanation of weak non-specific suppression could be that crosses to mothers with a UAS-driven transgene alleviate a later, secondary stage of CI killing by reducing embryonic expression of the transgenic CidB toxin in older embryos. This might result from competitive binding of the Gal4 transcription factor onto the mother's UAS insertions, limiting binding to the transgenic *UAS-cidB* gene. Because of non-specific suppression, we urge caution about conclusions with suppression of transgenic CI. Suppression data should be backed by suppression analysis against natural bacteria induced CI, as we have done for P32 and Kap-α. We added commentary on these issues to the Discussion section.

> d\) For those not intimately familiar with recent CI literature, it would be helpful to include an explanation of why expression of both CidB/CidA is being driven in the male (Given the toxin (CidB)/ Antitoxin (CidA) model presented the rational for this approach is not obvious). The dual expression is also described in their Introduction with no additional explanation. Perhaps these sections could point the reader to an expanded Materials and methods section where the rational is fully explained.

We agree and have modified the Introduction to include a brief discussion of these points. We also added an additional subsection "Rationale for dual CidA and CidB transgenic CI expression" to the Materials and methods.

> 3\) Figure 5 strongly supports the capability of both P32 and Kap-α to suppress CI in the embryo. The relevance of P32 to CI is clear \-- maternally deposited P32 processes sperm-deposited paternal chromosomes in uninfected embryos and in CI, the paternal chromosomes fail to condensed properly at the first zygotic prophase. However, Kap-α has yet to be implicated in paternal genome processing post-fertilization. Do we know if Kap-α is maternally deposited? The absence of either IF- or Western -- based evidence that Kap-α is detectable prior to zygotic genome activation weakens the implied relevance of Kap-α to CI in nature. This needs to be addressed by the authors.

We thank the reviewer for these thoughtful comments. In our study, transgenically expressed Kap-α, and all our transgenes for that matter, should be maternally deposited because the plasmid pUASp-attb encodes a 3' UTR from the *Drosophila* K10 gene appended to the transgene insert. This 3'UTR was specifically added because it was shown to mediate oocyte localization of the K10 mRNA transcript (Serrano and Cohen, 1995). Pernille Rorth validated this in the original study, "Gal4 in the *Drosophila* female germline," which describes the construction and analysis of this vector. We added a note on this in the Materials and methods. We have not verified immunologically that any of the transgenically expressed proteins are deposited in the egg.

Regarding the question of whether naturally expressed Kap-α2 is maternally deposited, data suggest that this is likely the case because it is essential for female fertility and is thought to play a paralog-specific role in oogenesis. Overexpression of maternally deposited Kap-α via transgenic constructs complements female sterility induced by homozygous Kap-α2 knockouts (see Mason et al., 2002). We added a note on this in the Discussion.

> 4\) Related to above, do the authors imagine that the toxin targets different developmental events between sperm entry and the first zygotic division and that is why targets with different roles in this process emerged from the Drosophila-based screen? Do the authors imagine Kap-α and P32 act independently during this short developmental stage? What is the model?

CidB targeting of multiple embryonic events or substrates is possible but will take a good deal of work to prove. Our data show that CidB physically interacts with Kap-α and P32, among other proteins. One can imagine a range of models to explain these interactions as well as the ability of the overexpressed proteins to suppress CidB toxicity. One possible model is that CidB cleaves ubiquitin from both Kap-α and histone chaperones such as P32 (or histones themselves). Histone H2A and H2B are well characterized ubiquitylated proteins, and yeast Kap-α (Srp1) is ubiquitylated in vivo. There are data for ubiquitin-H2B and histone chaperones cooperating in replication-independent nucleosome assembly (Wu et al., 2017). In this model, ubiquitylation of Kap-α is needed for its import function, at least for certain substrates such ubiquitin ligases or their cofactors that act on ubiquitylated histones/chaperones. CidB itself might also be imported into the male pronucleus via Kap-α. In the nucleus, CidB activity against ubiquitylated histones or histone chaperones may further impair histone deposition (but not protamine removal). Overexpressed Kap-α, in this view, would enhance import of histone ubiquitylation factors to overcome the activity of the CidB against these proteins. In parallel, overexpression of histone chaperones such as P32 would enhance nucleosome assembly.

The above considerations are given in the extended Discussion.

> 5\) Also related to the above, a model that reconciles previous work showing that the earliest CI-defect in Drosophila embryos appears at prophase with the current work that shows that, based on CidB targets, CI compromises transition to nucleosome-based chromatin on paternal DNA. Based on the discovery that CidB binds P32, we would expect instead that sperm-deposited DNA would fail to decondense after sperm entry and ultimately fail to participate at all in the first zygotic mitosis.

We appreciate the reviewers pointing out this subtlety. Landmann et al., 2009, who studied CI embryo cytology, reported normal removal of protamines, normal decondensation of paternal chromatin in CI embryos, but impaired deposition of maternal histone H3.3. This yielded a failure of paternal chromosomes to re-condense in a timely way as the embryos entered mitosis. We do not disagree with the Landmann et al. study and indeed have found it crucial to informing the analysis of our data. The simplest resolution to the findings that CidB binds P32 and that P32 in high dosage suppresses CI is CidB activity interferes specifically with nucleosome assembly but not protamine removal. Perhaps ubiquitylation is only required for the latter functionality of P32. We add a note on this in the Discussion. At this point, we do not definitively conclude that P32 is an actual substrate of CidB deubiquitylation. It might be equally likely, as in the model mentioned above, that CidB uses an interaction with P32 to bring it to the actual substrate(s), such as histone H2A or H2B. Our identification of the P32-CidB interaction now allows us to probe these hypotheses in detail.

> 6\) The proteomic analysis demonstrates that CidA binding to CidB\* does not compromise interactions with other proteins.

This statement is actually contradicted by our proteomic data (Figure 4) showing that CidA profoundly alters CidB\*-protein binding. For example, with only CidB\* on the column, it binds P32 and Kap-α2; but when complexed with CidA, it does not bind either of these targets. These findings lead directly to our inference that the rescue mechanism of CI by CidA is that it renders CidB incapable of associating with its relevant host targets.

> The (surprisingly?) expanded set of interactors under this treatment warrants further comment.

There are definitely additional interactors that might be relevant to the CI mechanism. Our initial aim has been to focus on hits that either came from orthogonal screens (Kap- α) or were internally reinforced by other hits (both P32 and Nap1 are protamine-histone exchange factors, but P32 was the stronger hit). Nevertheless, we now discuss additional interactors found in proteomic data, specifically the fact that multiple AP-3 complex subunits were identified (Table 1B) in the Discussion.

> 7\) The Introduction could benefit tremendously from some restructuring and addition of important background information. For example, the second paragraph of the Introduction asserts that \'CidA and CidB proteins precisely mimic naturel CI.\' However, the reader does not yet know what \'natural CI\' looks like. Indeed, the word \"embryo\" has not yet appeared in the Introduction. The fifth paragraph of the Introduction could be moved up to help explain natural CI. In addition, CidB^wPip^ (Introduction, second paragraph) is not explicitly defined as derived from Culex pipiens. The third paragraph of the Introduction could also benefit from additional information about how CidA is \'inferred from bi-directional crosses.\" Generally, the Introduction appears to be written in \"short format\" and so fails to completely introduce the system to the uninitiated reader.

We agree and have restructured the Introduction as suggested into a longer and more detailed form.

> 8\) Where are the data for the high copy suppressor plasmids encoding the other sub-cloned genes that did not exhibit suppressor activity? (Subsection "Yeast Dosage Suppressors of cidB Toxicity, last paragraph; Figure 2). These data should be included as a supplement.

We have added all our screening results as Figure 2---figure supplement 2.

> 9\) Why were only Kap-α and P32 used in the final CI suppression assay? Do the other candidates not suppress CI?

For this study we counted 53,347 *Drosophila* eggs. Due to the time, expense, and labor needed to perform CI crosses with high N, we focused our analysis on factors that we thought would be most relevant. We extensively analyzed these data with transgenic crosses and wild-type CI crosses. However, in response to the reviewers, we have now added two additional control crosses to the final suppression analysis, including crosses against Kap-α1 and cidA*^w^*^Mel^ (Figure 5D). These additional crosses add further to rigor and reproducibility of our results.

> 10\) The Discussion does not directly address many of key findings of the manuscript and how it relates to previous work on CI. For example, the Abstract states \"CidB targets nuclear-protein import and protamine-histone exchange and that CidA rescues embryos by restricting CidB access to its target\" yet no mention is made of this idea in the Discussion. There are other examples as well.

We have expanded and restructured the Discussion.
